- In second reversal, FDA gives uniQure a green light to seek accelerated approvalRegulatory flexibility appears to be back on the FDA’s menu following the departures of Marty Makary and Vinay Prasad. At the center of the debate, once again, is the ...Endpoints · 1mo ago↗ source
- Jazz turns to AbCellera for T cell engagers in up to $4.1B partnershipFor much of its first decade, Canadian antibody developer AbCellera signed partnership after partnership, securing 40 biopharma alliances that led to more than a dozen clinical-stage drug candidate…Endpoints · 1mo ago↗ source
- Update: Spot Bio launches with $40M to study non-viral gene therapy for muscular dystrophyA startup with operations in California and China has quietly begun tests of a genetic medicine that could restore dystrophin, the vital muscle protein that is broken or missing in people born with…